| abstract |
An inhalable dry powder composition comprising acetylsalicylic acid in the form of particles having a mass median aerodynamic diameter (MMAD) in the range of about 1 μm to about 5 μm. The dry powder composition may contain a pharmaceutically acceptable excipient, for example a stearate, in an amount of from about 0.04% (w / w) to about 0.06% (w / w), or about 0.4 % (w / w) and about 0.6% (w / w) of the composition. |